Try our Advanced Search for more refined results
Health
-
March 10, 2026
Wash. Justices Seem Open To Palestinian's Racial Bias Claim
The Washington State Supreme Court appeared somewhat receptive on Tuesday to a Palestinian patient's argument that an unfavorable jury verdict in her medical malpractice trial was tainted by racism, with several justices concerned that the defense had described the accused doctor as "from this part of the world" during openings.
-
March 10, 2026
UnitedHealth Must Reveal Nitty-Gritty In Claim Denial AI Case
A Minnesota federal judge has ordered UnitedHealth Group to hand over discovery on the secretive algorithm it uses to manage Medicare Advantage claims, ruling Monday that the insurer must disclose internal records detailing whether the technology was designed to override the clinical judgment of doctors.
-
March 10, 2026
Sanofi Says Judge Botched Insulin Device Patent Listings
Sanofi-Aventis sparred with drug wholesalers over a Massachusetts federal magistrate judge's pronouncements that the parties should go to trial on claims the pharmaceutical giant used improper insulin device patent listings to anticompetitively protect the blockbuster Lantus insulin pen from competition.
-
March 10, 2026
Lab's Aetna Payment Suit Survives, But With Deep Cuts
A Connecticut federal judge ruled Aetna and its parent company, CVS Health Corp., must face a pared down lawsuit from a medical laboratory alleging it is owed $20.6 million in unpaid invoices.
-
March 10, 2026
FDA To Consider Coffee, 'Spice' E-Cig Flavors
The U.S. Food and Drug Administration on Monday indicated that it would be willing to consider e-cigarette flavors shown to be less attractive to youth, like coffee or spices, a move that's come under fire from public health advocates.
-
March 10, 2026
Wash. To Set Its Own Vaccine Schedule Under New State Law
Washington Gov. Bob Ferguson has signed legislation that requires health plans to cover vaccines and other preventive care recommended by the state rather than the federal government, joining a movement toward states setting their own recommendations.
-
March 10, 2026
4th Circ. Backs W.Va.'s Trans Care Coverage Exclusion
The Fourth Circuit said Tuesday that West Virginia's Medicaid coverage exclusion for gender-affirming care passes constitutional muster and does not discriminate based on sex, basing its conclusion on a U.S. Supreme Court ruling that upheld Tennessee's ban on gender-affirming care for minors.
-
March 10, 2026
CVS Can't 'Relitigate' Price-Gouging Class Cert.
A Rhode Island federal judge refused to narrow the certified classes of health plans alleging CVS schemed with pharmacy benefit managers to overcharge insured health plans for generic drugs, finding that PBM Express Scripts' refusal to produce its contracts changes nothing about how the classes will be assessed.
-
March 10, 2026
2nd Circ. Revives Geico's Suit Over Acupuncture Referrals
A lower court erred in granting summary judgment to Geico after the insurer sued over reimbursements to an acupuncturist involved in what Geico said was a kickback scheme, the Second Circuit ruled Tuesday, finding the district court misinterpreted a state law detailing requirements for referrals and no-fault payments.
-
March 10, 2026
Liberty Mutual Says Mich. Clinics Ran RICO Billing Scheme
Liberty Mutual has sued a group of Michigan medical providers, a physician and related businesses, claiming the collective ran a coordinated no-fault billing scheme that steered auto accident patients through affiliated providers to generate unnecessary medical bills.
-
March 10, 2026
Former Conn. Prosecutor Can Stay On Generic-Drug Case
Connecticut's former assistant attorney general can continue to represent insurers Humana and Molina Healthcare Inc. in multidistrict litigation over alleged price-fixing of generic drugs, after the Pennsylvania federal judge overseeing the case agreed Monday with a report that the attorney has no information that had not already been shared.
-
March 10, 2026
Medtronic Expands Vascular Device Line With $550M Deal
Medtronic said Tuesday it will acquire privately held Scientia Vascular for about $550 million, strengthening its portfolio of devices used to treat stroke and other neurovascular conditions.
-
March 10, 2026
AFSCME Sues Trump Admin Over $600M Health Funding Cuts
The American Federation of State, County and Municipal Employees is seeking to block a federal government directive to cancel more than $600 million in public health grants administered by the Centers for Disease Control and Prevention, alleging that the directive was issued to target Democratic-led states.
-
March 10, 2026
Judge Urges Resolution In NY Nursing Home Ch. 11
A New York bankruptcy court Tuesday pushed back the disclosure statement hearing in the Chapter 11 case of Long Island nursing home operator Cold Spring Acquisition, after the debtor said it is continuing to negotiate with its official committee of unsecured creditors over the administration of its liquidation plan.
-
March 09, 2026
Fla. Judge Finds Leapfrog's Hospital Ratings Deceptive, Unfair
A Florida federal judge ordered hospital ratings nonprofit Leapfrog to revoke poor safety grades it issued to five hospitals owned by Tenet Healthcare Corp., finding the group's approach to evaluating the hospitals and publicizing its findings was unfair and deceptive.
-
March 09, 2026
Texas AG Gets Temporary Ban On Chest Binder Sales
A Texas state judge has issued a temporary restraining order against a New York-based online retailer of undergarments and chest binders for young women and teens from selling its clothing in the Lone Star State.
-
March 09, 2026
Vehicle Manufacturer Strikes Deal In Tobacco Surcharge Suit
Commercial vehicle manufacturer International Motors LLC has agreed to end a proposed class action claiming it unlawfully charges employees who use tobacco products an additional $600 per year for health insurance without providing an alternative to the fee, according to a filing in Illinois federal court.
-
March 09, 2026
Abbott Formula Linked To 'Horrible' Gut Disease, Ill. Jury Told
Abbott Laboratories' preterm baby formula was a contributing factor that caused four premature infants born in Illinois to develop a "devastating and painful intestinal disease," and the company has failed to warn parents and physicians that the cow's milk-based formula is a risk factor for the condition, a Cook County jury heard Monday.
-
March 09, 2026
Abortion Rights Group, SD Agree to End Gas Station Ads Row
An abortion rights group can no longer post advertisements at gas stations in South Dakota that promote abortion care, the South Dakota attorney general's office announced on Monday, saying that the group and the state have reached an agreement in a pair of lawsuits over the advertising campaign.
-
March 09, 2026
Verano Receipts Out Medical Pot Users, Suit Claims
An Illinois man is suing cannabis giant Verano Holdings LLC in state court, alleging that it is in violation of state and federal privacy laws because it includes the buyer's name and date of birth on receipts for purchases at its dispensaries.
-
March 09, 2026
Novo, Hims & Hers Make Up, Agree To Sell GLP-1s Together
Novo Nordisk A/S will start selling its GLP-1 medications on Hims & Hers Health Inc.'s platform as part of a deal that resolves the pharmaceutical company's patent infringement lawsuit against the telehealth provider, the companies announced Monday.
-
March 09, 2026
Biopharma Brass Hid Drug Trial Risks, Derivative Suit Says
Brass of Ultragenyx Pharmaceutical Inc. are facing shareholder derivative claims they caused the company to overstate prospects for a drug to treat a bone disease, hurting investors and opening the company up to liability when its share prices fell following disappointing clinical trial news.
-
March 09, 2026
DC Circ. Skeptical That Review Of $100K H-1B Fee Is Foreclosed
Two members of a D.C. Circuit panel appeared uneasy Monday with the Trump administration's argument that the president's proclamation imposing a $100,000 payment for new H-1B petitions and accompanying agency actions implementing it are beyond judicial review.
-
March 09, 2026
McGuireWoods Beats Sun Pharma's DQ Bid In NJ Suit
A New Jersey federal court has denied Sun Pharmaceutical's bid to disqualify McGuireWoods LLP from representing pharmaceutical company Biofrontera in litigation over the alleged breach of a settlement agreement, ruling the firm's continued representation won't harm Sun Pharmaceutical and will avoid significant harm to Biofrontera.
-
March 09, 2026
3 Convicted Of Using Dental Practice To Defraud Medicare
A Pennsylvania jury on Monday convicted two of three brothers and an associate accused of using their dental practice to defraud Medicare by submitting bogus reimbursement claims, installing unapproved dental implants and doctoring visa paperwork to recruit workers from abroad.
Expert Analysis
-
SDNY OpenAI Order Clarifies Preservation Standards For AI
The Southern District of New York’s recent order in the OpenAI copyright infringement litigation, denying discovery of The New York Times' artificial intelligence technology use, clarifies that traditional preservation benchmarks apply to AI content, relieving organizations from using a “keep everything” approach, says Philip Favro at Favro Law.
-
4 Strategies To Ensure Courts Calculate Restitution Correctly
Recent reversals of restitution orders across the federal appeals courts indicate that some lower courts are misapplying fundamental restitution principles, so defense attorneys should consider a few ways to vigilantly press these issues with the sentencing judge, says Wesley Gorman at Comber Miller.
-
Assessing The Future Of The HIPAA Reproductive Health Rule
In light of a Texas federal court's recent decision to strike down a U.S. Department of Health and Human Services rule aimed to protect the privacy of patients seeking abortions and gender-affirming care, entities are at least temporarily relieved from compliance obligations, but tensions are likely to continue for the foreseeable future, says Liz Heddleston at Woods Rogers.
-
Opinion
Expert Reports Can't Replace Facts In Securities Fraud Cases
The Ninth Circuit's 2023 decision in Nvidia v. Ohman Fonder — and the U.S. Supreme Court's punt on the case in 2024 — could invite the meritless securities litigation the Private Securities Litigation Reform Act was designed to prevent by substituting expert opinions for facts to substantiate complaint assertions, say attorneys at A&O Shearman.
-
Opinion
High Court, Not A Single Justice, Should Decide On Recusal
As public trust in the U.S. Supreme Court continues to decline, the court should adopt a collegial framework in which all justices decide questions of recusal together — a reform that respects both judicial independence and due process for litigants, say Michael Broyde at Emory University and Hayden Hall at the U.S. Bankruptcy Court for the District of Delaware.
-
Series
Traveling Solo Makes Me A Better Lawyer
Traveling by myself has taught me to assess risk, understand tone and stay calm in high-pressure situations, which are not only useful life skills, but the foundation of how I support my clients, says Lacey Gutierrez at Group Five Legal.
-
Opinion
DOJ's Tracing Rule For Pandemic Loan Fraud Is Untenable
In conducting investigations related to COVID-19 relief fraud, the government's assertion that loan proceeds are nonfungible and had to have been segregated from other funds is unsupported by underlying legislation, precedent or the language establishing similar federal relief programs, say Sharon McCarthy, Jay Nanavati and Lasya Ravulapati at Kostelanetz.
-
New Health AI Guidance Features A Provider-Centric Approach
New guidance from the Joint Commission and Coalition for Health AI regarding the responsible use of artificial intelligence in healthcare deviates from preexisting guidance by recommending a comprehensive framework for using AI tools, focusing on healthcare provider organizations rather than on AI developers, say attorneys at Ropes & Gray.
-
Series
Law School's Missed Lessons: Client Service
Law school teaches you how to interpret the law, but it doesn't teach you some of the key ways to keeping clients satisfied, lessons that I've learned in the most unexpected of places: a book on how to be a butler, says Gregory Ramos at Armstrong Teasdale.
-
How Occasional Activists Have Reshaped Proxy Fights
The sophistication and breadth of first-time activist engagement continue to shape corporate governance and strategic outcomes, as evidenced across corporate annual meetings this summer, meaning advisers should anticipate continued innovation in tactics, increased regulatory complexity, and a persistent focus on board accountability, say attorneys at MoFo.
-
Bid Protest Spotlight: Documentation, Overrides, Eligibility
Recent decisions by the U.S. Court of Federal Claims and the U.S. Government Accountability Office illustrate the importance of contemporaneous documentation in proposal evaluations, the standards for an agency’s override of a Competition in Contracting Act stay, and the regulatory requirements for small business joint ventures, says Cody Fisher at MoFo.
-
Shutdown Imperils Telehealth Access For Medicare Patients
The federal government shutdown that commenced on Oct. 1 coincided with the expiration of certain telehealth flexibilities that had preserved expansive access to telehealth services for Medicare beneficiaries following COVID-19, creating significant legal and financial uncertainty for healthcare providers and patients, say attorneys at Robinson & Cole.
-
Mass. Ruling May Pave New Avenue To Target Subpoenas
A Massachusetts federal court’s recent decision to quash a subpoena seeking information on gender-affirming care at Boston Children’s Hospital is a significant departure from courts' deferential approach to subpoena enforcement, and may open a new pathway for practitioners challenging investigative tools in the future, say attorneys at Gibson Dunn.
-
What To Expect After FDA Warnings To GLP-1 Compounders
The U.S. Food and Drug Administration's recent warning letters to companies advertising compounded versions of GLP-1 medications raise questions not just about the enforcement outlook for marketing such products, but also about the future of drug compounding as a whole, say attorneys at Spencer Fane.
-
Why Justices Seem Inclined To Curtail Del. Affidavit Statute
After recent oral argument before the U.S. Supreme Court in Berk v. Choy — asking whether Delaware's affidavit-of-merit statute applies in federal diversity actions, or whether the Federal Rules of Civil Procedure displace the state requirement — it appears the court is poised to simplify the standard approach, says Eric Weitz of The Weitz Law Firm.